|
|
|
Insider
Information: |
Hillsberg Sanford |
Relationship: |
Director |
City: |
Bala Cynwyd |
State: |
PA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
3,214,950 |
|
Indirect Shares
|
234,647 |
|
|
Direct
Value |
$79,730 |
|
|
Indirect Value
|
$1,120,626 |
|
|
Total
Shares |
3,449,597 |
|
|
Total
Value |
$1,200,356 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Cordex Pharma Inc |
CDXP |
10% Owner |
2007-01-04 |
3,158,000 |
2007-01-04 |
49,200 |
Premium* |
|
SELLAS Life Sciences Group Inc |
SLS |
Director |
2017-10-10 |
56,950 |
2014-02-03 |
85,447 |
Premium* |
|
Iovance Biotherapeutics Inc |
IOVA |
Director |
|
0 |
2016-08-25 |
100,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SLS |
SELLAS Life Sciences Grou... |
Director |
|
2017-10-10 |
4 |
A |
$0.38 |
$7,979 |
D/D |
20,997 |
56,950 |
0 |
- |
|
SLS |
SELLAS Life Sciences Grou... |
Director |
|
2017-07-06 |
4 |
A |
$0.59 |
$7,900 |
D/D |
13,390 |
35,953 |
0 |
- |
|
SLS |
SELLAS Life Sciences Grou... |
Director |
|
2017-04-10 |
4 |
A |
$0.59 |
$7,902 |
D/D |
13,394 |
22,563 |
0 |
- |
|
SLS |
SELLAS Life Sciences Grou... |
Director |
|
2017-01-20 |
4 |
A |
$1.98 |
$7,916 |
D/D |
3,998 |
9,169 |
0 |
- |
|
IOVA |
Iovance Biotherapeutics I... |
Director |
|
2016-08-25 |
4/A |
AS |
$8.71 |
$178,612 |
I/I |
(20,500) |
100,000 |
0 |
- |
|
IOVA |
Iovance Biotherapeutics I... |
Director |
|
2016-08-24 |
4/A |
AS |
$9.10 |
$304,800 |
I/I |
(33,500) |
120,500 |
0 |
- |
|
IOVA |
Iovance Biotherapeutics I... |
Director |
|
2016-08-22 |
4 |
S |
$9.11 |
$491,740 |
I/I |
(54,000) |
100,000 |
0 |
- |
|
IOVA |
Iovance Biotherapeutics I... |
Director |
|
2015-09-08 |
4 |
S |
$7.13 |
$117,645 |
I/I |
(16,500) |
154,000 |
0 |
- |
|
IOVA |
Iovance Biotherapeutics I... |
Director |
|
2015-09-04 |
4 |
S |
$6.84 |
$109,440 |
I/I |
(16,000) |
170,500 |
0 |
- |
|
IOVA |
Iovance Biotherapeutics I... |
Director |
|
2015-08-03 |
4 |
S |
$8.15 |
$264,875 |
I/I |
(32,500) |
186,500 |
0 |
- |
|
IOVA |
Iovance Biotherapeutics I... |
Director |
|
2015-05-06 |
4 |
S |
$10.00 |
$500,000 |
I/I |
(50,000) |
219,000 |
0 |
- |
|
IOVA |
Iovance Biotherapeutics I... |
Director |
|
2015-01-28 |
4 |
D |
$0.00 |
$0 |
I/I |
(25,000) |
0 |
0 |
- |
|
IOVA |
Iovance Biotherapeutics I... |
Director |
|
2014-12-16 |
4 |
A |
$0.00 |
$0 |
I/I |
25,000 |
25,000 |
0 |
- |
|
SLS |
SELLAS Life Sciences Grou... |
Director |
|
2014-02-03 |
5 |
GD |
$0.00 |
$0 |
I/I |
10,000 |
85,447 |
0 |
- |
|
SLS |
SELLAS Life Sciences Grou... |
Director |
|
2014-01-30 |
4 |
GD |
$0.00 |
$0 |
I/I |
15,000 |
95,447 |
0 |
- |
|
SLS |
SELLAS Life Sciences Grou... |
Director |
|
2014-01-30 |
4 |
OE |
$1.18 |
$321,500 |
D/D |
250,000 |
267,974 |
0 |
- |
|
SLS |
SELLAS Life Sciences Grou... |
Director |
|
2014-01-30 |
4 |
S |
$5.41 |
$1,352,500 |
D/D |
(250,000) |
17,974 |
0 |
- |
|
SLS |
SELLAS Life Sciences Grou... |
Director |
|
2014-01-17 |
4 |
S |
$6.93 |
$1,385,000 |
I/I |
(200,000) |
110,447 |
0 |
- |
|
SLS |
SELLAS Life Sciences Grou... |
Director |
|
2014-01-14 |
4 |
D |
$6.96 |
$170,005 |
I/I |
(24,426) |
310,447 |
0 |
- |
|
SLS |
SELLAS Life Sciences Grou... |
Director |
|
2014-01-14 |
4 |
OE |
$0.85 |
$170,000 |
I/I |
200,000 |
334,873 |
0 |
- |
|
IOVA |
Iovance Biotherapeutics I... |
Director |
|
2013-12-30 |
4 |
A |
$0.00 |
$0 |
I/I |
67,500 |
269,000 |
0 |
- |
|
SLS |
SELLAS Life Sciences Grou... |
Director |
|
2013-12-12 |
4 |
D |
$4.19 |
$36,000 |
I/I |
(8,592) |
134,873 |
0 |
- |
|
SLS |
SELLAS Life Sciences Grou... |
Director |
|
2013-12-12 |
4 |
OE |
$0.72 |
$36,000 |
I/I |
50,000 |
143,375 |
0 |
- |
|
SLS |
SELLAS Life Sciences Grou... |
Director |
|
2013-11-12 |
4 |
GD |
$0.00 |
$0 |
I/I |
37,001 |
93,375 |
0 |
- |
|
IOVA |
Iovance Biotherapeutics I... |
Director |
|
2013-11-05 |
4 |
A |
$0.00 |
$0 |
I/I |
67,500 |
201,500 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|